| Financial Year |
March 31 2023 |
| Monetary Funds |
287,186,705.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
150,450,000.00 |
| Accounts Receivable |
25,529,490.09 |
| Advances to Suppliers |
1,574,293.57 |
| Other Receivables |
18,849,855.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,090,265.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
444,089,026.89 |
| Other Current Assets |
1,458,428,857.01 |
| Total Current Assets |
2,469,198,493.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
471,134,058.63 |
| Long-term Equity Investment |
-- |
| Investment Properties |
63,592,635.71 |
| Fixed Assetes |
121,097,873.56 |
| Under-construction Projects |
517,431.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,780,739.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
514,270.19 |
| Deferred Income Tax Assets |
238,876,253.52 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,824,928,185.41 |
| Total Assets |
4,294,126,679.28 |
| Short-Term Loans |
247,626,648.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
41,161,246.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,829,256.99 |
| Taxes Payable |
36,769,275.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,111,812.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,749,233.13 |
| Other Current Liabilities |
11,197.83 |
| Sub-Total of Current Liabilities |
452,528,514.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
14,572,383.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
35,131,379.17 |
| Deferred Income Tax Liabilities |
21,208,983.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,764,380.93 |
| Total Liabilities |
525,292,895.11 |
| Paid-In Capital(Or Share Stock) |
788,933,815.00 |
| Capital Surplus |
406,471,974.72 |
| Surplus Reserve |
361,742,294.44 |
| LESS:Treasury Stock |
80,072,469.35 |
| Undistributed Profits |
2,308,834,064.74 |
| Minority Stockholder's Interest |
31,717,731.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,737,116,052.50 |
| Owner's Equity（Stockholder's Equity） |
3,768,833,784.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,294,126,679.28 |
